Mark Swanson

Corporate Officer/Principal bei Gel Med Sciences, Inc.

Health Technology

Consumer Services

Commercial Services

Aktive Positionen von Mark Swanson

Unternehmen	Position	Beginn	Ende
Gel Med Sciences, Inc. Gel Med Sciences, Inc. Pharmaceuticals: MajorHealth Technology Gel Med Sciences, Inc. engages in the development of animal and human healthcare products. It offers ovugel that utilizes the company's gel drug delivery system to improve the timing of artificial inseminations in pig herds. The company was founded by Joseph S Duffey in 1999 and is headquartered in Wayne, PA.	Corporate Officer/Principal	-	-
	Technik-/Wissenschafts-/F&E-Leiter	04.01.2010	-

Unternehmen	Position	Beginn	Ende
DNX Transgenic Sciences DNX Transgenic Sciences Miscellaneous Commercial ServicesCommercial Services Part of Revvity, Inc., DNX Transgenic Sciences is an American company that provides contract research services and transgenic animal technologies to the biomedical research community. The company is based in NJ. DNX Transgenic Sciences was acquired by Xenogen Corp., a subsidiary of Revvity, Inc. from Nordion (Canada), Inc. on November 13, 2000 for $35 million.	Corporate Officer/Principal	-	-
Sandoz Pharmaceuticals Corp.	Technik-/Wissenschafts-/F&E-Leiter	-	-

University of Connecticut

Doctorate Degree

International

Vereinigte Staaten

Operativ

Chief Tech/Sci/R&D Officer	2
Corporate Officer/Principal	2
Doctorate Degree	1

Sektoral

Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Private Unternehmen	3
Gel Med Sciences, Inc. Gel Med Sciences, Inc. Pharmaceuticals: MajorHealth Technology Gel Med Sciences, Inc. engages in the development of animal and human healthcare products. It offers ovugel that utilizes the company's gel drug delivery system to improve the timing of artificial inseminations in pig herds. The company was founded by Joseph S Duffey in 1999 and is headquartered in Wayne, PA.	Health Technology
Sandoz Pharmaceuticals Corp.
DNX Transgenic Sciences DNX Transgenic Sciences Miscellaneous Commercial ServicesCommercial Services Part of Revvity, Inc., DNX Transgenic Sciences is an American company that provides contract research services and transgenic animal technologies to the biomedical research community. The company is based in NJ. DNX Transgenic Sciences was acquired by Xenogen Corp., a subsidiary of Revvity, Inc. from Nordion (Canada), Inc. on November 13, 2000 for $35 million.	Commercial Services